カテゴリ： LP Information, 世界, 医療/バイオ

臭化グリコピロニウムAPIの世界市場2022-2028：USP、EP

■ 英語タイトル：Global Glycopyrronium Bromide API Market Growth 2022-2028

調査会社LP Information社が発行したリサーチレポート（データ管理コード：LP22DC4993）■ 発行会社/調査会社：LP Information
■ 商品コード：LP22DC4993
■ 発行日：2022年12月
■ 調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
■ 産業分野：医薬品
■ ページ数：122
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※LP Information社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[臭化グリコピロニウムAPIの世界市場2022-2028：USP、EP]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

臭化グリコピロニウムAPIのグローバル市場規模は、2021年のxxx百万ドルから2028年までにxxx百万ドルに増加すると推定されており、2022年～2028年の年平均成長率（CAGR）はxx%を示しています。COVID-19とロシア・ウクライナ戦争の不確実性を念頭に置いて、さまざまな最終用途部門に対するパンデミックの直接的および間接的な影響を継続的に追跡・分析しています。これらのインサイトは、主要な市場要因としてレポートに含まれています。
臭化グリコピロニウムAPIのアジア太平洋市場は、2022年にxxx百万ドルの市場規模が見込まれ、2022年～2028年にかけて約xx%のCAGRで成長すると予想されています。臭化グリコピロニウムAPIの米国市場は、2022年にxxx百万ドルの規模があり、2022年～2028年にかけて約xx%のCAGRで成長すると予想されています。臭化グリコピロニウムAPIのヨーロッパ市場は、2022年にxxx百万ドルの規模が見込まれ、2022年～2028年にかけて約xx%のCAGRで成長すると予想されています。臭化グリコピロニウムAPIの中国市場は、2022年にxxx百万ドルの規模があり、2022年～2028年にかけて約xx%のCAGRで成長すると予想されています。

世界の主要な臭化グリコピロニウムAPI関連企業としては、Neuraxpharm、 Seqens、 Cerbios Pharma、 Harman Finochem、 Tai Heng Industry、 Amsa Spa、 Boehringer Ingelheim、 Hovione、 Sifavitor srl、 Hainan Poly Pharm、 Suven Life Sciences、 Resonance Laboratories、 Hikma Pharmaceuticals、 Endo International、 Siegfried、 Dipharma、 Aurobindo Pharma、 Synergene Active Ingredients、 Aragen Life Sciences、 Tooba Pharmaceuticals、 Cipla、 Guangzhou Tosun Pharmaceutical、 Olon、 Khandelwal Laboratories、 Stason Pharmaceuticalsなどをカバーしています。売上の面では世界最大の2社が2021年にほぼxx%の市場シェアを占めています。

*** レポート範囲 ***

この最新のレポートはすべての重要な側面をカバーしながら臭化グリコピロニウムAPIのグローバル市場に関する深いインサイトを提供します。これは、市場のマクロな概要から、市場規模、競争環境、開発動向、ニッチ市場、主要な市場ドライバーと課題、バリュー チェーン分析などのミクロの詳細にまで及びます。当レポートは読者がパンデミックおよびロシア・ウクライナ戦争中に世界中で臭化グリコピロニウムAPI市場シナリオがどのように変化したかを理解できるように定量的データと定性的データの両方を使用して、臭化グリコピロニウムAPIのグローバル市場の全体像を提供することを目的としています。

分析の対象となる基準年は2021年で、市場の予測は2022年～2028年までのものです。

*** 市場セグメンテーション ***

この調査では臭化グリコピロニウムAPI市場を細分化し、種類別 (USP、EP)、用途別 (多汗症、重症よだれ、COPD)、および地域別 (アジア太平洋、アメリカ州、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：USP、EP

・用途別区分：多汗症、重症よだれ、COPD

・地域別区分
アメリカ州（アメリカ、カナダ、メキシコ、ブラジル）
APAC/アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

*** 各章の紹介 ***
第1章：臭化グリコピロニウムAPIの範囲、調査方法など
第2章：エグゼクティブサマリー、世界の臭化グリコピロニウムAPI市場規模 (販売量、売上) およびCAGR、地域別・種類別・用途別、2017年～2022年までの推移データ、および2028年までの市場予測
第3章：企業別臭化グリコピロニウムAPIの販売量、売上、平均価格、グローバル市場シェア、および業界ランキング
第4章：地域別および国別の臭化グリコピロニウムAPIの販売量と売上（米国、カナダ、ヨーロッパ、中国、日本、韓国、東南アジア、インド、ラテンアメリカ、中東・アフリカなど）
第5/6/7/8章：アメリカ州、アジア太平洋、ヨーロッパ、中東・アフリカの国別、種類別の販売セグメント
第9章：市場動向、市場予測、機会、将来の市場に影響を与える経済動向の分析
第10章：製造コスト構造分析
第11章：販売チャンネル、販売業者および顧客
第12章：地域別、国別、種類別、用途別の世界の臭化グリコピロニウムAPI市場規模予測
第13章：主要企業の包括的な企業プロファイル
第14章：調査の結果

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：臭化グリコピロニウムAPIの年間販売量2017-2028、地域別現状・将来分析
・臭化グリコピロニウムAPIの種類別セグメント：USP、EP
・臭化グリコピロニウムAPIの種類別販売量：2017-2022年の販売量、売上、市場シェア、販売価格
・臭化グリコピロニウムAPIの用途別セグメント：多汗症、重症よだれ、COPD
・臭化グリコピロニウムAPIの用途別販売量：2017-2022年の販売量、売上、市場シェア、販売価格

企業別世界の臭化グリコピロニウムAPI市場
・企業別のグローバル臭化グリコピロニウムAPI市場データ：2020-2022年の年間販売量、市場シェア
・企業別の臭化グリコピロニウムAPIの年間売上：2020-2022年の売上、市場シェア
・企業別の臭化グリコピロニウムAPI販売価格
・主要企業の臭化グリコピロニウムAPI生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

臭化グリコピロニウムAPIの地域別レビュー
・地域別の臭化グリコピロニウムAPI市場規模2017-2022：年間販売量、売上
・主要国別の臭化グリコピロニウムAPI市場規模2017-2022：年間販売量、売上
・アメリカ州の臭化グリコピロニウムAPI販売の成長
・アジア太平洋の臭化グリコピロニウムAPI販売の成長
・ヨーロッパの臭化グリコピロニウムAPI販売の成長
・中東・アフリカの臭化グリコピロニウムAPI販売の成長

アメリカ州市場
・アメリカ州の国別の臭化グリコピロニウムAPI販売量、売上（2017-2022）
・アメリカ州の臭化グリコピロニウムAPIの種類別販売量
・アメリカ州の臭化グリコピロニウムAPIの用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋（APAC）市場
・アジア太平洋の国別の臭化グリコピロニウムAPI販売量、売上（2017-2022）
・アジア太平洋の臭化グリコピロニウムAPIの種類別販売量
・アジア太平洋の臭化グリコピロニウムAPIの用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の臭化グリコピロニウムAPI販売量、売上（2017-2022）
・ヨーロッパの臭化グリコピロニウムAPIの種類別販売量
・ヨーロッパの臭化グリコピロニウムAPIの用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の臭化グリコピロニウムAPI販売量、売上（2017-2022）
・中東・アフリカの臭化グリコピロニウムAPIの種類別販売量
・中東・アフリカの臭化グリコピロニウムAPIの用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・臭化グリコピロニウムAPIの製造コスト構造分析
・臭化グリコピロニウムAPIの製造プロセス分析
・臭化グリコピロニウムAPIの産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・臭化グリコピロニウムAPIの主要なグローバル販売業者
・臭化グリコピロニウムAPIの主要なグローバル顧客

地域別の臭化グリコピロニウムAPI市場予測レビュー
・地域別の臭化グリコピロニウムAPI市場規模予測（2023-2028）
・アメリカ州の国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・臭化グリコピロニウムAPIの種類別市場規模予測
・臭化グリコピロニウムAPIの用途別市場規模予測

主要企業分析
Neuraxpharm、 Seqens、 Cerbios Pharma、 Harman Finochem、 Tai Heng Industry、 Amsa Spa、 Boehringer Ingelheim、 Hovione、 Sifavitor srl、 Hainan Poly Pharm、 Suven Life Sciences、 Resonance Laboratories、 Hikma Pharmaceuticals、 Endo International、 Siegfried、 Dipharma、 Aurobindo Pharma、 Synergene Active Ingredients、 Aragen Life Sciences、 Tooba Pharmaceuticals、 Cipla、 Guangzhou Tosun Pharmaceutical、 Olon、 Khandelwal Laboratories、 Stason Pharmaceuticals
・企業情報
・臭化グリコピロニウムAPI製品
・臭化グリコピロニウムAPI販売量、売上、価格、粗利益（2020-2022）
・主要ビジネス概要
・最新動向

調査の結果

The global market for Glycopyrronium Bromide API is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Glycopyrronium Bromide API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Glycopyrronium Bromide API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Glycopyrronium Bromide API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Glycopyrronium Bromide API market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Glycopyrronium Bromide API players cover Neuraxpharm, Seqens, Cerbios Pharma, Harman Finochem and Tai Heng Industry, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

[Report Coverage]
This latest report provides a deep insight into the global Glycopyrronium Bromide API market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Glycopyrronium Bromide API market, with both quantitative and qualitative data, to help readers understand how the Glycopyrronium Bromide API market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.

[Market Segmentation]
The study segments the Glycopyrronium Bromide API market and forecasts the market size by Type (USP and EP,), by Application (Hyperhidrosis, Severe Drooling and COPD,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
USP
EP
Segmentation by application
Hyperhidrosis
Severe Drooling
COPD
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Neuraxpharm
Seqens
Cerbios Pharma
Harman Finochem
Tai Heng Industry
Amsa Spa
Boehringer Ingelheim
Hovione
Sifavitor srl
Hainan Poly Pharm
Suven Life Sciences
Resonance Laboratories
Hikma Pharmaceuticals
Endo International
Siegfried
Dipharma
Aurobindo Pharma
Synergene Active Ingredients
Aragen Life Sciences
Tooba Pharmaceuticals
Cipla
Guangzhou Tosun Pharmaceutical
Olon
Khandelwal Laboratories
Stason Pharmaceuticals

[Chapter Introduction]
Chapter 1: Scope of Glycopyrronium Bromide API, Research Methodology, etc.
Chapter 2: Executive Summary, global Glycopyrronium Bromide API market size (sales and revenue) and CAGR, Glycopyrronium Bromide API market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Glycopyrronium Bromide API sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Glycopyrronium Bromide API sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Glycopyrronium Bromide API market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Neuraxpharm, Seqens, Cerbios Pharma, Harman Finochem, Tai Heng Industry, Amsa Spa, Boehringer Ingelheim, Hovione and Sifavitor srl, etc.
Chapter 14: Research Findings and Conclusion

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Glycopyrronium Bromide API Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Glycopyrronium Bromide API by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Glycopyrronium Bromide API by Country/Region, 2017, 2022 & 2028
2.2 Glycopyrronium Bromide API Segment by Type
2.2.1 USP
2.2.2 EP
2.3 Glycopyrronium Bromide API Sales by Type
2.3.1 Global Glycopyrronium Bromide API Sales Market Share by Type (2017-2022)
2.3.2 Global Glycopyrronium Bromide API Revenue and Market Share by Type (2017-2022)
2.3.3 Global Glycopyrronium Bromide API Sale Price by Type (2017-2022)
2.4 Glycopyrronium Bromide API Segment by Application
2.4.1 Hyperhidrosis
2.4.2 Severe Drooling
2.4.3 COPD
2.5 Glycopyrronium Bromide API Sales by Application
2.5.1 Global Glycopyrronium Bromide API Sale Market Share by Application (2017-2022)
2.5.2 Global Glycopyrronium Bromide API Revenue and Market Share by Application (2017-2022)
2.5.3 Global Glycopyrronium Bromide API Sale Price by Application (2017-2022)
3 Global Glycopyrronium Bromide API by Company
3.1 Global Glycopyrronium Bromide API Breakdown Data by Company
3.1.1 Global Glycopyrronium Bromide API Annual Sales by Company (2020-2022)
3.1.2 Global Glycopyrronium Bromide API Sales Market Share by Company (2020-2022)
3.2 Global Glycopyrronium Bromide API Annual Revenue by Company (2020-2022)
3.2.1 Global Glycopyrronium Bromide API Revenue by Company (2020-2022)
3.2.2 Global Glycopyrronium Bromide API Revenue Market Share by Company (2020-2022)
3.3 Global Glycopyrronium Bromide API Sale Price by Company
3.4 Key Manufacturers Glycopyrronium Bromide API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Glycopyrronium Bromide API Product Location Distribution
3.4.2 Players Glycopyrronium Bromide API Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Glycopyrronium Bromide API by Geographic Region
4.1 World Historic Glycopyrronium Bromide API Market Size by Geographic Region (2017-2022)
4.1.1 Global Glycopyrronium Bromide API Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Glycopyrronium Bromide API Annual Revenue by Geographic Region
4.2 World Historic Glycopyrronium Bromide API Market Size by Country/Region (2017-2022)
4.2.1 Global Glycopyrronium Bromide API Annual Sales by Country/Region (2017-2022)
4.2.2 Global Glycopyrronium Bromide API Annual Revenue by Country/Region
4.3 Americas Glycopyrronium Bromide API Sales Growth
4.4 APAC Glycopyrronium Bromide API Sales Growth
4.5 Europe Glycopyrronium Bromide API Sales Growth
4.6 Middle East & Africa Glycopyrronium Bromide API Sales Growth
5 Americas
5.1 Americas Glycopyrronium Bromide API Sales by Country
5.1.1 Americas Glycopyrronium Bromide API Sales by Country (2017-2022)
5.1.2 Americas Glycopyrronium Bromide API Revenue by Country (2017-2022)
5.2 Americas Glycopyrronium Bromide API Sales by Type
5.3 Americas Glycopyrronium Bromide API Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Glycopyrronium Bromide API Sales by Region
6.1.1 APAC Glycopyrronium Bromide API Sales by Region (2017-2022)
6.1.2 APAC Glycopyrronium Bromide API Revenue by Region (2017-2022)
6.2 APAC Glycopyrronium Bromide API Sales by Type
6.3 APAC Glycopyrronium Bromide API Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Glycopyrronium Bromide API by Country
7.1.1 Europe Glycopyrronium Bromide API Sales by Country (2017-2022)
7.1.2 Europe Glycopyrronium Bromide API Revenue by Country (2017-2022)
7.2 Europe Glycopyrronium Bromide API Sales by Type
7.3 Europe Glycopyrronium Bromide API Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Glycopyrronium Bromide API by Country
8.1.1 Middle East & Africa Glycopyrronium Bromide API Sales by Country (2017-2022)
8.1.2 Middle East & Africa Glycopyrronium Bromide API Revenue by Country (2017-2022)
8.2 Middle East & Africa Glycopyrronium Bromide API Sales by Type
8.3 Middle East & Africa Glycopyrronium Bromide API Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Glycopyrronium Bromide API
10.3 Manufacturing Process Analysis of Glycopyrronium Bromide API
10.4 Industry Chain Structure of Glycopyrronium Bromide API
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Glycopyrronium Bromide API Distributors
11.3 Glycopyrronium Bromide API Customer
12 World Forecast Review for Glycopyrronium Bromide API by Geographic Region
12.1 Global Glycopyrronium Bromide API Market Size Forecast by Region
12.1.1 Global Glycopyrronium Bromide API Forecast by Region (2023-2028)
12.1.2 Global Glycopyrronium Bromide API Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Glycopyrronium Bromide API Forecast by Type
12.7 Global Glycopyrronium Bromide API Forecast by Application
13 Key Players Analysis
13.1 Neuraxpharm
13.1.1 Neuraxpharm Company Information
13.1.2 Neuraxpharm Glycopyrronium Bromide API Product Offered
13.1.3 Neuraxpharm Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Neuraxpharm Main Business Overview
13.1.5 Neuraxpharm Latest Developments
13.2 Seqens
13.2.1 Seqens Company Information
13.2.2 Seqens Glycopyrronium Bromide API Product Offered
13.2.3 Seqens Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Seqens Main Business Overview
13.2.5 Seqens Latest Developments
13.3 Cerbios Pharma
13.3.1 Cerbios Pharma Company Information
13.3.2 Cerbios Pharma Glycopyrronium Bromide API Product Offered
13.3.3 Cerbios Pharma Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Cerbios Pharma Main Business Overview
13.3.5 Cerbios Pharma Latest Developments
13.4 Harman Finochem
13.4.1 Harman Finochem Company Information
13.4.2 Harman Finochem Glycopyrronium Bromide API Product Offered
13.4.3 Harman Finochem Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Harman Finochem Main Business Overview
13.4.5 Harman Finochem Latest Developments
13.5 Tai Heng Industry
13.5.1 Tai Heng Industry Company Information
13.5.2 Tai Heng Industry Glycopyrronium Bromide API Product Offered
13.5.3 Tai Heng Industry Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Tai Heng Industry Main Business Overview
13.5.5 Tai Heng Industry Latest Developments
13.6 Amsa Spa
13.6.1 Amsa Spa Company Information
13.6.2 Amsa Spa Glycopyrronium Bromide API Product Offered
13.6.3 Amsa Spa Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Amsa Spa Main Business Overview
13.6.5 Amsa Spa Latest Developments
13.7 Boehringer Ingelheim
13.7.1 Boehringer Ingelheim Company Information
13.7.2 Boehringer Ingelheim Glycopyrronium Bromide API Product Offered
13.7.3 Boehringer Ingelheim Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Boehringer Ingelheim Main Business Overview
13.7.5 Boehringer Ingelheim Latest Developments
13.8 Hovione
13.8.1 Hovione Company Information
13.8.2 Hovione Glycopyrronium Bromide API Product Offered
13.8.3 Hovione Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Hovione Main Business Overview
13.8.5 Hovione Latest Developments
13.9 Sifavitor srl
13.9.1 Sifavitor srl Company Information
13.9.2 Sifavitor srl Glycopyrronium Bromide API Product Offered
13.9.3 Sifavitor srl Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sifavitor srl Main Business Overview
13.9.5 Sifavitor srl Latest Developments
13.10 Hainan Poly Pharm
13.10.1 Hainan Poly Pharm Company Information
13.10.2 Hainan Poly Pharm Glycopyrronium Bromide API Product Offered
13.10.3 Hainan Poly Pharm Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Hainan Poly Pharm Main Business Overview
13.10.5 Hainan Poly Pharm Latest Developments
13.11 Suven Life Sciences
13.11.1 Suven Life Sciences Company Information
13.11.2 Suven Life Sciences Glycopyrronium Bromide API Product Offered
13.11.3 Suven Life Sciences Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Suven Life Sciences Main Business Overview
13.11.5 Suven Life Sciences Latest Developments
13.12 Resonance Laboratories
13.12.1 Resonance Laboratories Company Information
13.12.2 Resonance Laboratories Glycopyrronium Bromide API Product Offered
13.12.3 Resonance Laboratories Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Resonance Laboratories Main Business Overview
13.12.5 Resonance Laboratories Latest Developments
13.13 Hikma Pharmaceuticals
13.13.1 Hikma Pharmaceuticals Company Information
13.13.2 Hikma Pharmaceuticals Glycopyrronium Bromide API Product Offered
13.13.3 Hikma Pharmaceuticals Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Hikma Pharmaceuticals Main Business Overview
13.13.5 Hikma Pharmaceuticals Latest Developments
13.14 Endo International
13.14.1 Endo International Company Information
13.14.2 Endo International Glycopyrronium Bromide API Product Offered
13.14.3 Endo International Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Endo International Main Business Overview
13.14.5 Endo International Latest Developments
13.15 Siegfried
13.15.1 Siegfried Company Information
13.15.2 Siegfried Glycopyrronium Bromide API Product Offered
13.15.3 Siegfried Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Siegfried Main Business Overview
13.15.5 Siegfried Latest Developments
13.16 Dipharma
13.16.1 Dipharma Company Information
13.16.2 Dipharma Glycopyrronium Bromide API Product Offered
13.16.3 Dipharma Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Dipharma Main Business Overview
13.16.5 Dipharma Latest Developments
13.17 Aurobindo Pharma
13.17.1 Aurobindo Pharma Company Information
13.17.2 Aurobindo Pharma Glycopyrronium Bromide API Product Offered
13.17.3 Aurobindo Pharma Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Aurobindo Pharma Main Business Overview
13.17.5 Aurobindo Pharma Latest Developments
13.18 Synergene Active Ingredients
13.18.1 Synergene Active Ingredients Company Information
13.18.2 Synergene Active Ingredients Glycopyrronium Bromide API Product Offered
13.18.3 Synergene Active Ingredients Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Synergene Active Ingredients Main Business Overview
13.18.5 Synergene Active Ingredients Latest Developments
13.19 Aragen Life Sciences
13.19.1 Aragen Life Sciences Company Information
13.19.2 Aragen Life Sciences Glycopyrronium Bromide API Product Offered
13.19.3 Aragen Life Sciences Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Aragen Life Sciences Main Business Overview
13.19.5 Aragen Life Sciences Latest Developments
13.20 Tooba Pharmaceuticals
13.20.1 Tooba Pharmaceuticals Company Information
13.20.2 Tooba Pharmaceuticals Glycopyrronium Bromide API Product Offered
13.20.3 Tooba Pharmaceuticals Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Tooba Pharmaceuticals Main Business Overview
13.20.5 Tooba Pharmaceuticals Latest Developments
13.21 Cipla
13.21.1 Cipla Company Information
13.21.2 Cipla Glycopyrronium Bromide API Product Offered
13.21.3 Cipla Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Cipla Main Business Overview
13.21.5 Cipla Latest Developments
13.22 Guangzhou Tosun Pharmaceutical
13.22.1 Guangzhou Tosun Pharmaceutical Company Information
13.22.2 Guangzhou Tosun Pharmaceutical Glycopyrronium Bromide API Product Offered
13.22.3 Guangzhou Tosun Pharmaceutical Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Guangzhou Tosun Pharmaceutical Main Business Overview
13.22.5 Guangzhou Tosun Pharmaceutical Latest Developments
13.23 Olon
13.23.1 Olon Company Information
13.23.2 Olon Glycopyrronium Bromide API Product Offered
13.23.3 Olon Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 Olon Main Business Overview
13.23.5 Olon Latest Developments
13.24 Khandelwal Laboratories
13.24.1 Khandelwal Laboratories Company Information
13.24.2 Khandelwal Laboratories Glycopyrronium Bromide API Product Offered
13.24.3 Khandelwal Laboratories Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.24.4 Khandelwal Laboratories Main Business Overview
13.24.5 Khandelwal Laboratories Latest Developments
13.25 Stason Pharmaceuticals
13.25.1 Stason Pharmaceuticals Company Information
13.25.2 Stason Pharmaceuticals Glycopyrronium Bromide API Product Offered
13.25.3 Stason Pharmaceuticals Glycopyrronium Bromide API Sales, Revenue, Price and Gross Margin (2020-2022)
13.25.4 Stason Pharmaceuticals Main Business Overview
13.25.5 Stason Pharmaceuticals Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Glycopyrronium Bromide API Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Glycopyrronium Bromide API Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of USP
Table 4. Major Players of EP
Table 5. Global Glycopyrronium Bromide API Sales by Type (2017-2022) & (K Units)
Table 6. Global Glycopyrronium Bromide API Sales Market Share by Type (2017-2022)
Table 7. Global Glycopyrronium Bromide API Revenue by Type (2017-2022) & ($ million)
Table 8. Global Glycopyrronium Bromide API Revenue Market Share by Type (2017-2022)
Table 9. Global Glycopyrronium Bromide API Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Glycopyrronium Bromide API Sales by Application (2017-2022) & (K Units)
Table 11. Global Glycopyrronium Bromide API Sales Market Share by Application (2017-2022)
Table 12. Global Glycopyrronium Bromide API Revenue by Application (2017-2022)
Table 13. Global Glycopyrronium Bromide API Revenue Market Share by Application (2017-2022)
Table 14. Global Glycopyrronium Bromide API Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Glycopyrronium Bromide API Sales by Company (2020-2022) & (K Units)
Table 16. Global Glycopyrronium Bromide API Sales Market Share by Company (2020-2022)
Table 17. Global Glycopyrronium Bromide API Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Glycopyrronium Bromide API Revenue Market Share by Company (2020-2022)
Table 19. Global Glycopyrronium Bromide API Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Glycopyrronium Bromide API Producing Area Distribution and Sales Area
Table 21. Players Glycopyrronium Bromide API Products Offered
Table 22. Glycopyrronium Bromide API Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Glycopyrronium Bromide API Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Glycopyrronium Bromide API Sales Market Share Geographic Region (2017-2022)
Table 27. Global Glycopyrronium Bromide API Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Glycopyrronium Bromide API Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Glycopyrronium Bromide API Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Glycopyrronium Bromide API Sales Market Share by Country/Region (2017-2022)
Table 31. Global Glycopyrronium Bromide API Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Glycopyrronium Bromide API Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Glycopyrronium Bromide API Sales by Country (2017-2022) & (K Units)
Table 34. Americas Glycopyrronium Bromide API Sales Market Share by Country (2017-2022)
Table 35. Americas Glycopyrronium Bromide API Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Glycopyrronium Bromide API Revenue Market Share by Country (2017-2022)
Table 37. Americas Glycopyrronium Bromide API Sales by Type (2017-2022) & (K Units)
Table 38. Americas Glycopyrronium Bromide API Sales Market Share by Type (2017-2022)
Table 39. Americas Glycopyrronium Bromide API Sales by Application (2017-2022) & (K Units)
Table 40. Americas Glycopyrronium Bromide API Sales Market Share by Application (2017-2022)
Table 41. APAC Glycopyrronium Bromide API Sales by Region (2017-2022) & (K Units)
Table 42. APAC Glycopyrronium Bromide API Sales Market Share by Region (2017-2022)
Table 43. APAC Glycopyrronium Bromide API Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Glycopyrronium Bromide API Revenue Market Share by Region (2017-2022)
Table 45. APAC Glycopyrronium Bromide API Sales by Type (2017-2022) & (K Units)
Table 46. APAC Glycopyrronium Bromide API Sales Market Share by Type (2017-2022)
Table 47. APAC Glycopyrronium Bromide API Sales by Application (2017-2022) & (K Units)
Table 48. APAC Glycopyrronium Bromide API Sales Market Share by Application (2017-2022)
Table 49. Europe Glycopyrronium Bromide API Sales by Country (2017-2022) & (K Units)
Table 50. Europe Glycopyrronium Bromide API Sales Market Share by Country (2017-2022)
Table 51. Europe Glycopyrronium Bromide API Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Glycopyrronium Bromide API Revenue Market Share by Country (2017-2022)
Table 53. Europe Glycopyrronium Bromide API Sales by Type (2017-2022) & (K Units)
Table 54. Europe Glycopyrronium Bromide API Sales Market Share by Type (2017-2022)
Table 55. Europe Glycopyrronium Bromide API Sales by Application (2017-2022) & (K Units)
Table 56. Europe Glycopyrronium Bromide API Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Glycopyrronium Bromide API Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Glycopyrronium Bromide API Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Glycopyrronium Bromide API Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Glycopyrronium Bromide API Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Glycopyrronium Bromide API Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Glycopyrronium Bromide API Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Glycopyrronium Bromide API Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Glycopyrronium Bromide API Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Glycopyrronium Bromide API
Table 66. Key Market Challenges & Risks of Glycopyrronium Bromide API
Table 67. Key Industry Trends of Glycopyrronium Bromide API
Table 68. Glycopyrronium Bromide API Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Glycopyrronium Bromide API Distributors List
Table 71. Glycopyrronium Bromide API Customer List
Table 72. Global Glycopyrronium Bromide API Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Glycopyrronium Bromide API Sales Market Forecast by Region
Table 74. Global Glycopyrronium Bromide API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Glycopyrronium Bromide API Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Glycopyrronium Bromide API Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Glycopyrronium Bromide API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Glycopyrronium Bromide API Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Glycopyrronium Bromide API Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Glycopyrronium Bromide API Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Glycopyrronium Bromide API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Glycopyrronium Bromide API Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Glycopyrronium Bromide API Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Glycopyrronium Bromide API Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Glycopyrronium Bromide API Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Glycopyrronium Bromide API Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Glycopyrronium Bromide API Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Glycopyrronium Bromide API Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Glycopyrronium Bromide API Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Glycopyrronium Bromide API Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Glycopyrronium Bromide API Revenue Market Share Forecast by Application (2023-2028)
Table 92. Neuraxpharm Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 93. Neuraxpharm Glycopyrronium Bromide API Product Offered
Table 94. Neuraxpharm Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. Neuraxpharm Main Business
Table 96. Neuraxpharm Latest Developments
Table 97. Seqens Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 98. Seqens Glycopyrronium Bromide API Product Offered
Table 99. Seqens Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Seqens Main Business
Table 101. Seqens Latest Developments
Table 102. Cerbios Pharma Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 103. Cerbios Pharma Glycopyrronium Bromide API Product Offered
Table 104. Cerbios Pharma Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Cerbios Pharma Main Business
Table 106. Cerbios Pharma Latest Developments
Table 107. Harman Finochem Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 108. Harman Finochem Glycopyrronium Bromide API Product Offered
Table 109. Harman Finochem Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Harman Finochem Main Business
Table 111. Harman Finochem Latest Developments
Table 112. Tai Heng Industry Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 113. Tai Heng Industry Glycopyrronium Bromide API Product Offered
Table 114. Tai Heng Industry Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Tai Heng Industry Main Business
Table 116. Tai Heng Industry Latest Developments
Table 117. Amsa Spa Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 118. Amsa Spa Glycopyrronium Bromide API Product Offered
Table 119. Amsa Spa Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. Amsa Spa Main Business
Table 121. Amsa Spa Latest Developments
Table 122. Boehringer Ingelheim Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 123. Boehringer Ingelheim Glycopyrronium Bromide API Product Offered
Table 124. Boehringer Ingelheim Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Boehringer Ingelheim Main Business
Table 126. Boehringer Ingelheim Latest Developments
Table 127. Hovione Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 128. Hovione Glycopyrronium Bromide API Product Offered
Table 129. Hovione Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Hovione Main Business
Table 131. Hovione Latest Developments
Table 132. Sifavitor srl Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 133. Sifavitor srl Glycopyrronium Bromide API Product Offered
Table 134. Sifavitor srl Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Sifavitor srl Main Business
Table 136. Sifavitor srl Latest Developments
Table 137. Hainan Poly Pharm Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 138. Hainan Poly Pharm Glycopyrronium Bromide API Product Offered
Table 139. Hainan Poly Pharm Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Hainan Poly Pharm Main Business
Table 141. Hainan Poly Pharm Latest Developments
Table 142. Suven Life Sciences Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 143. Suven Life Sciences Glycopyrronium Bromide API Product Offered
Table 144. Suven Life Sciences Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Suven Life Sciences Main Business
Table 146. Suven Life Sciences Latest Developments
Table 147. Resonance Laboratories Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 148. Resonance Laboratories Glycopyrronium Bromide API Product Offered
Table 149. Resonance Laboratories Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Resonance Laboratories Main Business
Table 151. Resonance Laboratories Latest Developments
Table 152. Hikma Pharmaceuticals Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 153. Hikma Pharmaceuticals Glycopyrronium Bromide API Product Offered
Table 154. Hikma Pharmaceuticals Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Hikma Pharmaceuticals Main Business
Table 156. Hikma Pharmaceuticals Latest Developments
Table 157. Endo International Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 158. Endo International Glycopyrronium Bromide API Product Offered
Table 159. Endo International Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Endo International Main Business
Table 161. Endo International Latest Developments
Table 162. Siegfried Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 163. Siegfried Glycopyrronium Bromide API Product Offered
Table 164. Siegfried Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Siegfried Main Business
Table 166. Siegfried Latest Developments
Table 167. Dipharma Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 168. Dipharma Glycopyrronium Bromide API Product Offered
Table 169. Dipharma Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 170. Dipharma Main Business
Table 171. Dipharma Latest Developments
Table 172. Aurobindo Pharma Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 173. Aurobindo Pharma Glycopyrronium Bromide API Product Offered
Table 174. Aurobindo Pharma Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 175. Aurobindo Pharma Main Business
Table 176. Aurobindo Pharma Latest Developments
Table 177. Synergene Active Ingredients Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 178. Synergene Active Ingredients Glycopyrronium Bromide API Product Offered
Table 179. Synergene Active Ingredients Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 180. Synergene Active Ingredients Main Business
Table 181. Synergene Active Ingredients Latest Developments
Table 182. Aragen Life Sciences Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 183. Aragen Life Sciences Glycopyrronium Bromide API Product Offered
Table 184. Aragen Life Sciences Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 185. Aragen Life Sciences Main Business
Table 186. Aragen Life Sciences Latest Developments
Table 187. Tooba Pharmaceuticals Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 188. Tooba Pharmaceuticals Glycopyrronium Bromide API Product Offered
Table 189. Tooba Pharmaceuticals Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 190. Tooba Pharmaceuticals Main Business
Table 191. Tooba Pharmaceuticals Latest Developments
Table 192. Cipla Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 193. Cipla Glycopyrronium Bromide API Product Offered
Table 194. Cipla Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 195. Cipla Main Business
Table 196. Cipla Latest Developments
Table 197. Guangzhou Tosun Pharmaceutical Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 198. Guangzhou Tosun Pharmaceutical Glycopyrronium Bromide API Product Offered
Table 199. Guangzhou Tosun Pharmaceutical Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 200. Guangzhou Tosun Pharmaceutical Main Business
Table 201. Guangzhou Tosun Pharmaceutical Latest Developments
Table 202. Olon Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 203. Olon Glycopyrronium Bromide API Product Offered
Table 204. Olon Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 205. Olon Main Business
Table 206. Olon Latest Developments
Table 207. Khandelwal Laboratories Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 208. Khandelwal Laboratories Glycopyrronium Bromide API Product Offered
Table 209. Khandelwal Laboratories Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 210. Khandelwal Laboratories Main Business
Table 211. Khandelwal Laboratories Latest Developments
Table 212. Stason Pharmaceuticals Basic Information, Glycopyrronium Bromide API Manufacturing Base, Sales Area and Its Competitors
Table 213. Stason Pharmaceuticals Glycopyrronium Bromide API Product Offered
Table 214. Stason Pharmaceuticals Glycopyrronium Bromide API Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 215. Stason Pharmaceuticals Main Business
Table 216. Stason Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Glycopyrronium Bromide API
Figure 2. Glycopyrronium Bromide API Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Glycopyrronium Bromide API Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Glycopyrronium Bromide API Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Glycopyrronium Bromide API Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of USP
Figure 10. Product Picture of EP
Figure 11. Global Glycopyrronium Bromide API Sales Market Share by Type in 2021
Figure 12. Global Glycopyrronium Bromide API Revenue Market Share by Type (2017-2022)
Figure 13. Glycopyrronium Bromide API Consumed in Hyperhidrosis
Figure 14. Global Glycopyrronium Bromide API Market: Hyperhidrosis (2017-2022) & (K Units)
Figure 15. Glycopyrronium Bromide API Consumed in Severe Drooling
Figure 16. Global Glycopyrronium Bromide API Market: Severe Drooling (2017-2022) & (K Units)
Figure 17. Glycopyrronium Bromide API Consumed in COPD
Figure 18. Global Glycopyrronium Bromide API Market: COPD (2017-2022) & (K Units)
Figure 19. Global Glycopyrronium Bromide API Sales Market Share by Application (2017-2022)
Figure 20. Global Glycopyrronium Bromide API Revenue Market Share by Application in 2021
Figure 21. Glycopyrronium Bromide API Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Glycopyrronium Bromide API Revenue Market Share by Company in 2021
Figure 23. Global Glycopyrronium Bromide API Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Glycopyrronium Bromide API Revenue Market Share by Geographic Region in 2021
Figure 25. Global Glycopyrronium Bromide API Sales Market Share by Region (2017-2022)
Figure 26. Global Glycopyrronium Bromide API Revenue Market Share by Country/Region in 2021
Figure 27. Americas Glycopyrronium Bromide API Sales 2017-2022 (K Units)
Figure 28. Americas Glycopyrronium Bromide API Revenue 2017-2022 ($ Millions)
Figure 29. APAC Glycopyrronium Bromide API Sales 2017-2022 (K Units)
Figure 30. APAC Glycopyrronium Bromide API Revenue 2017-2022 ($ Millions)
Figure 31. Europe Glycopyrronium Bromide API Sales 2017-2022 (K Units)
Figure 32. Europe Glycopyrronium Bromide API Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Glycopyrronium Bromide API Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Glycopyrronium Bromide API Revenue 2017-2022 ($ Millions)
Figure 35. Americas Glycopyrronium Bromide API Sales Market Share by Country in 2021
Figure 36. Americas Glycopyrronium Bromide API Revenue Market Share by Country in 2021
Figure 37. United States Glycopyrronium Bromide API Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Glycopyrronium Bromide API Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Glycopyrronium Bromide API Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Glycopyrronium Bromide API Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Glycopyrronium Bromide API Sales Market Share by Region in 2021
Figure 42. APAC Glycopyrronium Bromide API Revenue Market Share by Regions in 2021
Figure 43. China Glycopyrronium Bromide API Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Glycopyrronium Bromide API Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Glycopyrronium Bromide API Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Glycopyrronium Bromide API Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Glycopyrronium Bromide API Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Glycopyrronium Bromide API Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Glycopyrronium Bromide API Sales Market Share by Country in 2021
Figure 50. Europe Glycopyrronium Bromide API Revenue Market Share by Country in 2021
Figure 51. Germany Glycopyrronium Bromide API Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Glycopyrronium Bromide API Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Glycopyrronium Bromide API Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Glycopyrronium Bromide API Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Glycopyrronium Bromide API Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Glycopyrronium Bromide API Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Glycopyrronium Bromide API Revenue Market Share by Country in 2021
Figure 58. Egypt Glycopyrronium Bromide API Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Glycopyrronium Bromide API Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Glycopyrronium Bromide API Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Glycopyrronium Bromide API Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Glycopyrronium Bromide API Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Glycopyrronium Bromide API in 2021
Figure 64. Manufacturing Process Analysis of Glycopyrronium Bromide API
Figure 65. Industry Chain Structure of Glycopyrronium Bromide API
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

※関連データはありません。

※注目の調査資料
 ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(LP22DC4993 )"臭化グリコピロニウムAPIの世界市場2022-2028：USP、EP" (英文：Global Glycopyrronium Bromide API Market Growth 2022-2028)はLP Information社が調査・発行しており、H&Iグローバルリサーチが販売します。

◆H&Iグローバルリサーチのお客様（例）◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。